The results of the CABANA trial comparing ablation to drugs in the treatment of atrial fibrillation was the headline-story at the 2018 Heart Rhythm Society scientific sessions in Boston, held earlier this month, but there were many presentations of clinical data on new and established electrophysiology technologies. Here are a few highlights you may have missed.
St. Jude Medical Inc.Tendril pacemaker leads had a high-rate of failure over a short duration of follow-up in a single-single center experience reported at the HRS meeting.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?